The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control study-

Trial Profile

The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control study-

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jun 2017

At a glance

  • Drugs Rabeprazole (Primary) ; Rebamipide (Primary)
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2017 Status changed from recruiting to completed.
    • 02 Jan 2010 Planned number of patients changed from 240 to 100 as reported by University Hospital Medical Information Network - Japan.
    • 03 Feb 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top